Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : UBS reiterates its Neutral rating

11/17/2020 | 06:14am EST

Michael Leuchten from UBS retains his Neutral opinion on the stock. The target price has been revised upwards and is now set at EUR 129, compared with EUR 118 previously.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA 1.38% 143.05 Delayed Quote.0.53%
UBS GROUP AG -1.75% 12.92 Delayed Quote.5.45%
All news about MERCK KGAA
07:21aMERCK KGAA : DZ Bank gives a Buy rating
MD
03:35aPFIZER : Germany's Merck Secure European Commission Approval for Bladder Cancer ..
MT
02:40aEuropean Commission Authorizes Use Of Merck-Pfizer Cancer Drug Bavencio
MT
01/22MERCK KGAA : Independant Research sticks Neutral
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
01/21MERCK KGAA : Bernstein remains Neutral
MD
01/21MERCK KGAA : JP Morgan maintains a Buy rating
MD
01/21MERCK KGAA : UBS reaffirms its Neutral rating
MD
01/21MERCK : Discontinues Phase III Clinical Trial For Lung Cancer Drug On Failure To..
MT
More news
Financials
Sales 2020 17 362 M 21 071 M 21 071 M
Net income 2020 1 977 M 2 399 M 2 399 M
Net Debt 2020 11 147 M 13 528 M 13 528 M
P/E ratio 2020 31,0x
Yield 2020 0,99%
Capitalization 62 195 M 75 424 M 75 480 M
EV / Sales 2020 4,22x
EV / Sales 2021 3,93x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 139,28 €
Last Close Price 141,10 €
Spread / Highest target 19,8%
Spread / Average Target -1,29%
Spread / Lowest Target -28,4%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA0.53%74 677
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD15.70%27 883
KYOWA KIRIN CO., LTD.3.70%14 378
BETTA PHARMACEUTICALS CO., LTD.32.16%8 898
YUHAN CORPORATION-3.06%4 265
RECIPHARM AB (PUBL)3.74%2 769